Publications

Indexed Peer-reviewed Articles
  1. Kopecky SL . Effects of methylprednisolone sodium succinate on experimental noncardiogenic pulmonary edema. Intensive Care Med. 1981; 7:121-124. PMID:6783692.
  2. Kopecky SL . Pneumomediastinum: pitfalls in diagnosis and management. Minn Med. 1984 Dec; 67(12):683-4. PMID:6513911.
  3. Kopecky SL , Callahan JA, Tajik AJ, Seward JB. Percutaneous pericardial catheter drainage: report of 42 consecutive cases. Am J Cardiol. 1986 Sep 15; 58(7):633-5. PMID:3751934.
  4. Kopecky SL , Gersh BJ, McGoon MD, Whisnant JP, Holmes DR, Ilstrup DM, Frye RL. The natural history of lone atrial fibrillation. A population-based study over three decades. N Engl J Med. 1987 Sep 10; 317(11):669-74. PMID:3627174.
  5. Kopecky SL , Gersh BJ. Dilated cardiomyopathy and myocarditis: natural history, etiology, clinical manifestations, and management. Curr Probl Cardiol. 1987 Oct;12:575-647. PMID:3322687.
  6. Kopecky SL , Gersh BJ, McGoon MD, Mair DD, Porter CJ, Ilstrup DM, McGoon DC, Kirklin JW, Danielson GK. Long-term outcome of patients undergoing surgical repair of isolated pulmonary valve stenosis. Follow-up at 20-30 years. Circulation. 1988 Nov; 78(5 Pt 1):1150-6. PMID:3180374.
  7. Kopecky SL . Management decisions in lone atrial fibrillation. Hosp Pract (Off Ed) 1992 Jun 15; 27(6):135-8, 143, 147-50. PMID:1597491.
  8. Zhu WX, Oh JK, Kopecky SL , Schaff HV, Tajik AJ. Mitral regurgitation due to ruptured chordae tendineae in patients with hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol. 1992 Jul; 20(1):242-7.PMID:1607533.
  9. McBride R, Chesebro JH, Wiebers DO, Holland AE, Linker S, Bardsley WT, Kopecky SL , Litin SC, Meissner I, Zerbe DM, Flaker GC, Webel R, Nolte B, Stevenson P, Byer J, Jenkins JS, Wright W, Anderson DC, Asinger RW, et al. Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation--stroke prevention in atrial fibrillation II study. Lancet. 1994 Mar 19; 343:687-691. PMID:7905569.
  10. Reeder GS, Kopecky SL . Thrombolysis in acute myocardial infarction: t-PA for everyone? MayoClin Proc.1994 Aug; 69(8):796-9. PMID:8035639.
  11. Wright RS, Kopecky SL . Streptokinase: a review. P T. 1995; 20(11 Suppl):4s-11s.
  12. Wright RS, Kopecky SL , Nishimura RA. Echocardiography in acute myocardial infarction. ACC Current Journal Review. 1996; 5(6):24-27.
  13. Blackshear JL, Kopecky SL , Litin SC, Safford RE, Hammill SC. Management of atrial fibrillation in adults: prevention of thromboembolism and symptomatic treatment. Mayo Clin Proc. 1996 Feb; 71(2):150-60. PMID:8577189. DOI:10.1016/S0025-6196(11)64507-2.
  14. Farkouh ME, Smars PA, Reeder GS, Zinsmeister AR, Evans RW, Meloy TD, Kopecky SL , Allen M, Allison TG, Gibbons RJ, Gabriel SE. Clinical trial of a chest-painobservation unit for patients with unstable angina. N Engl J Med. 1998 Dec 24;339(26):1882-1888.PMID:9862943.
  15. Kopecky SL . Idiopathic atrial fibrillation: prevalence, course, treatment, and prognosis. Journal of Thrombosis & Thrombolysis. 1999 Jan; 7(1):27-31. PMID:10337357.
  16. Kopecky SL , Gersh BJ, McGoon MD, Chu CP, Ilstrup DM, Chesebro JH, Whisnant JP. Lone atrial fibrillation in elderly persons: a marker for cardiovascular risk. Arch Intern Med. 1999 May 24; 159(10):1118-22. PMID:10335690.
  17.  Handa N, Schaff HV, Morris JJ, Anderson BJ, Kopecky SL , Enriquez-Sarano M. Outcome of valve repair and the Cox maze procedure for mitral regurgitation and associated atrial fibrillation. J Thorac Cardiovasc Surg. 1999 Oct; 118(4):628-35. PMID:10504626.
  18. Liuzzo G, Kopecky SL , Frye RL, O'Fallon WM, Maseri A, Goronzy JJ, Weyand CM. Perturbation of the T-cell repertoire in patients with unstable angina. Circulation. 1999 Nov 23; 100(21):2135-9.PMID:10571971.
  19. Gussak I, Wright RS, Kopecky SL , Hammill SC. Exercise-induced ST segment elevation in Q wave leads in postinfarction patients: defining its meaning and utility in today's practice. Cardiology. 2000; 93(4):205-9.PMID:11025345.
  20. Gussak I, Brugada P, Brugada J, Wright RS, Kopecky SL , Chaitman BR, Bjerregaard P. Idiopathic short QT interval: a new clinical syndrome? Cardiology. 2000; 94(2):99-102. PMID:11173780.
  21. Gussak I, Wright RS, Bjerregaard P, Chaitman BR, Zhou SH, Hammill SC, Kopecky SL .False-negative and false-positive ECG diagnoses of Q wave myocardial infarction in the presence of right bundle-branch block. Cardiology. 2000; 94(3):165-72. PMID:11279322.
  22. Roger VL, Farkouh ME, Weston SA, Reeder GS, Jacobsen SJ, Zinsmeister AR, Yawn BP,Kopecky SL , Gabriel SE. Sex differences in evaluation and outcome of unstable angina. JAMA. 2000 Feb 2; 283(5):646-52. PMID:10665705.
  23. Sgura FA, Kopecky SL , Grill JP, Gibbons RJ. Supine exercise capacity identifies patients at low risk for perioperative cardiovascular events and predicts long-termsurvival. Am J Med. 2000 Mar; 108(4):334-6. PMID:11014727.
  24. Wright RS, Monnahan RL, Kopecky SL , Jones CT, Holmes DR Jr. Cardiac catheterization reduces resource utilization in patients with chronic chest pain. Catheter Cardiovasc Interv. 2000 Apr; 49(4):363-6. PMID:10751756.
  25. Gussak I, Chaitman BR, Kopecky SL , Nerbonne JM. Rapid ventricular repolarization in rodents: electrocardiographic manifestations, molecular mechanisms, and clinical insights. J Electrocardiol. 2000 Apr; 33(2):159-70.PMID:10819409.
  26. Liuzzo G, GoronzyJJ, YangH, Kopecky SL , Holmes DR, Frye RL, Weyand CM. Monoclonal T-cell proliferation and plaque instability in acute coronary syndromes. Circulation. 2000 Jun 27; 101(25):2883-8. PMID:10869258.
  27. Allison TG, Farkouh ME, Smars PA, Evans RW, Squires RW, Gabriel SE, Kopecky SL , Gibbons RJ, Reeder GS. Management of coronary risk factors by registered nurses versus usual care in patients with unstable angina pectoris (a chest pain evaluation in
  28. Lincoff AM, Harrington RA, Califf RM, Hochman JS, Guerci AD, Ohman EM, Pepine CJ,Kopecky SL , Kleiman NS, Pacchiana CM, Berdan LG, Kitt MM, Simoons ML, Topol EJ. Management of patients with acute coronary syndromes in the United States by platelet glycoprotein IIb/IIIa inhibition. Insights from the platelet glycoprotein IIb/IIIa in unstable angina: receptor suppression using integrilin therapy (PURSUIT) trial. Circulation. 2000 Sep 5; 102(10):1093-100.PMID:10973836.
  29. Miller WL, Wright RS, Grill JP, Kopecky SL . Improved survival after acute myocardialinfarction in patients with advanced Killip class. Clin Cardiol. 2000 Oct; 23(10):751-8. PMID:11061053.
  30. Wright RS, Kopecky SL , Reeder GS. Update on intravenous fibrinolytic therapy for acute myocardial infarction. Mayo Clin Proc. 2000 Nov; 75(11):1185-91; quiz 1192.PMID:11075749.
  31. Bybee KA, Wright RS, Williams BA, Murphy JG, Holmes DR Jr, Kopecky SL . Effect of concomitant or very early statin administration on in-hospital mortality and reinfarction in patients with acute myocardial infarction. Am J Cardiol. 2001 Mar 15; 87(6):771-4, A7.
    PMID:11249901.
  32. Liuzzo G, Vallejo AN, Kopecky SL , Frye RL, Holmes DR, Goronzy JJ, Weyand CM. Molecular fingerprint of interferon-gamma signaling in unstable angina. Circulation. 2001 Mar 20; 103(11):1509-14.PMID:11257077.
  33. Miller WL, Sgura FA, Kopecky SL , Asirvatham SJ, Williams BA, Wright RS, Reeder GS. Characteristics of presenting electrocardiograms of acute myocardial infarction from acommunity-based population predict short- and long-term mortality. Am J Cardiol. 2001 May 1; 87(9):1045-50. PMID:11348600.
  34. Sgura FA, Wright RS, Kopecky SL , Grill JP, Reeder GS. Length of stay in myocardial infarction. Cost Qual. 2001 Jun; 12-20, 25. PMID:11482251.
  35. Alexander KP, Newby LK, Hellkamp AS, Harrington RA, Peterson ED, Kopecky S , Langer A, O'Gara P, O'Connor CM, Daly RN, Califf RM, Khan S, Fuster V. Initiation of hormone replacement therapy after acute myocardial infarction is associated with more cardiac events during follow-up. J Am Coll Cardiol. 2001 Jul; 38(1):1-7. PMID:11451256.
  36. Al-Khatib SM, Pieper KS, Lee KL, Mahaffey KW, Hochman JS, Pepine CJ, Kopecky SL , Akkerhuis M, Stepinska J, Simoons ML, Topol EJ, Califf RM, Harrington RA. Atrial fibrillation and mortality among patients with acute coronary syndromes withoutST-segment elevation: results from the PURSUIT trial. Am J Cardiol. 2001 Jul 1; 88(1):A7,76-9.PMID:11423065.
  37. Suwaidi JA, Wright RS, Grill JP, Hensrud DD, Murphy JG, Squires RW, Kopecky SL . Obesity is associated with premature occurrence of acute myocardial infarction. Clin Cardiol. 2001 Aug; 24(8):542-7.PMID:11501605.
  38. Brilakis ES, Wright RS, Kopecky SL , Reeder GS, Williams BA, Miller WL. Bundle branch block as a predictor of long-term survival after acute myocardial infarction. Am J Cardiol. 2001 Aug 1; 88(3):205-9.PMID:11472694.
  39. Rusnak JM,Kopecky SL, Clements IP, Gibbons RJ, Holland AE, Peterman HS, Martin JS, Saoud JB, Feldman RL, Breisblatt WM, Simons M, Gessler CJ, Yu AS. An anti-CD11/CD18 monoclonal antibody in patients with acute myocardial infarction having percutaneous transluminal coronary angioplasty (the FESTIVAL study). Am J Cardiol. 2001 Sep 1; 88(5):482-7.PMID:11524054.
  40. O'Connor CM, Gattis WA, Hellkamp AS, Langer A, Larsen RL, Harrington RA, Berkowitz SD, O'Gara PT, Kopecky SL , Gheorghiade M, Daly R, Califf RM, Fuster V. Comparison of two aspirin doses on ischemic stroke in post-myocardial infarction patients in the warfarin (Coumadin) Aspirin Reinfarction Study (CARS). Am J Cardiol. 2001 Sep 1;88(5):541-6.PMID:11524065.
  41. Wright RS, Kopecky SL , Timm M, Pflaum DD, Carr C, Evers K, Bell J, Wabasha Heart Attack Team. Impact of community-based education on health care evaluation in patients with acute chest pain syndromes: the Wabasha Heart Attack Team (WHAT) project. Fam Pract. 2001 Oct; 18(5):537-9.PMID:11604379.
  42. Weyand CM, Goronzy JJ, Liuzzo G, Kopecky SL , Holmes DR Jr, Frye RL. T-cell immunity in acute coronary syndromes. Mayo Clin Proc. 2001 Oct; 76(10):1011-20. PMID:11605685. DOI:10.4065/76.10.1011.
  43. Mathew V, Farkouh ME, Gersh BJ, Rihal CS, Reeder GS, Grill DE, Urban LH, Kopecky SL , Chesebro JH, Holmes DR. Early coronary angiography improves long-term survivalin unstable angina. Am Heart J. 2001 Nov; 142(5):768-74.PMID:11685161.DOI:10.1067/mhj.2001.119126.
  44. Aviles JM, Whelan SE, Hernke DA, Williams BA, Kenny KE, O'Fallon WM, Kopecky SL . Intercessory prayer and cardiovascular disease progression in a coronary care unit population: a randomized controlled trial. Mayo Clin Proc. 2001 Dec; 76(12):1192-8. PMID:11761499. DOI:10.4065/76.12.1192.
  45. Nigam A, Kopecky SL . Therapeutic potential of monoclonal antibodies in myocardial reperfusion injury. Am J Cardiovasc Drugs. 2002; 2(6):367-76.PMID:14727952.
  46. Nakajima T, Schulte S, Warrington KJ, Kopecky SL , Frye RL, Goronzy JJ, Weyand CM.T-cell-mediated lysis of endothelial cells in acute coronary syndromes. Circulation. 2002 Feb 5; 105(5):570-5.PMID:11827921.
  47. Dusek JA, Sherwood JB, Friedman R, Myers P, Bethea CF, Levitsky S, Hill PC, Jain MK,Kopecky SL , Mueller PS, Lam P, Benson H, Hibberd PL. Study of the Therapeutic Effects of Intercessory Prayer (STEP): study design and research methods. Am Heart J. 2002 Apr;143(4):577-84.PMID:11923793.
  48. Brilakis ES, Mavrogiorgos NC, Kopecky SL , Rihal CC, Gersh BJ, Williams BA, Clements IP. Usefulness of QRS duration in the absence of bundle branch block as an early predictor of survival in non-ST elevation acute myocardial infarction. Am J Cardiol. 2002 May 1; 89(9):1013-8.PMID:11988187.
  49. Bybee KA, Wright RS, Kopecky SL . Effect of early statin therapy after acute coronary syndromes: a concise review of the recent data. Cardiol Rev. 2002 Sep-Oct; 10(5):301-5. PMID:12215193.
  50. Wright RS, Murphy JG, Bybee KA, Kopecky SL , LaBlanche JM. Statin lipid-loweringtherapy for acute myocardial infarction and unstable angina: efficacy and mechanism of benefit. Mayo Clin Proc. 2002 Oct; 77(10):1085-92. PMID:12374252. DOI:10.4065/77.10.1085.
  51. Wright RS, Reeder GS, Herzog CA, Albright RC, Williams BA, Dvorak DL, Miller WL, Murphy JG, Kopecky SL , Jaffe AS. Acute myocardial infarction and renal dysfunction: ahigh-risk combination. Ann Intern Med. 2002 Oct 1; 137(7):563-70. PMID:12353943.
  52. Aviles RJ, Wright RS, Aviles JM, McDonald F, Ballman K, Harker-Murray A, Scott C, Lauer MS, KopeckySL, Jaffe AS. Long-term prognosis of patients with clinical unstable angina pectoris without elevation of creatine kinase but with elevation of cardiac troponin I levels. Am J Cardiol. 2002 Oct 15; 90(8):875-8.PMID:12372578.
  53. Gumina RJ, Wright RS, Kopecky SL , Miller WL, Williams BA, Reeder GS, Murphy JG. Strong predictive value of TIMI risk score analysis for in-hospital and long-term survival of
  54. Murphy J, Wright RS, Gussak I, Williams B, Daly RN, Cain VA, Pieniaszek HJ, Sy SK, Ebling W, Simonson K, Wilcox RA, Kopecky SL . The use of roxifiban (DMP754), a novel oral platelet glycoprotein IIb/IIIa receptor inhibitor, in patients with stable coronary artery disease. Am J Cardiovasc Drugs. 2003; 3(2):101-12.PMID:14727937.
  55. Decker WW, Prina LD, Smars PA, Boggust AJ, Zinsmeister AR, Kopecky SL . Continuous 12-lead electrocardiographic monitoring in an emergency department chest pain unit: An assessment of potential clinical effect. Ann Emerg Med. 2003 Mar;41(3):342-51.PMID:12605201.
  56. Tedesco JV, Wright RS, Williams BA, Kopecky SL , Dvorak DL, Reeder GS, Miller WL, Mayo Coronary Care Unit Group. Effect of diabetes on the mortality risk of cardiogenic shock in a community-based population. Mayo Clin Proc. 2003 May; 78(5):561-6.PMID:12744542.
  57. Gami AS, Wright RS, Ballman KV, Kopecky SL , Hayes SN. Hormone replacement therapy and risk of acute myocardial infarction in postmenopausal women with diabetes mellitus. Am J Cardiol. 2003 May 15; 91(10):1275-7. PMID:12745121.
  58. Kopecky SL , Aviles RJ, Bell MR, Lobl JK, Tipping D, Frommell G, Ramsey K, Holland AE, Midei M, Jain A, Kellett M, Gibbons RJ, AmP579 Delivery for Myocardial Infarction REduction study. A randomized, double-blinded, placebo-controlled, dose-ranging study measuring the effect of an adenosine agonist on infarct size reduction in patients undergoing primary percutaneous transluminal coronary angioplasty: the ADMIRE (AmP579 Delivery for Myocardial Infarction REduction) study. Am Heart J. 2003 Jul;146(1):146-52. PMID:12851624. DOI:10.1016/S0002-8703(03)00172-8.
  59. Nakajima T, Goek O, Zhang XY, Kopecky SL , Frye RL, Goronzy JJ, Weyand CM. De novo expression of killer immunoglobulin-like receptors and signaling proteins regulates the cytotoxic function of CD4 T cells in acute coronary syndromes. Circ Res. 2003 Jul 25;93(2):106-13. PMID:12816883.
  60. Tedesco JV, Williams BA, Wright RS, Reeder GS, Dvorak D, Kopecky SL , Miller WL, Coronary Care Unit Group. Baseline comorbidities and treatment strategy in elderly patients are associated with outcome of cardiogenic shock in a community-based population. Am Heart J. 2003 Sep; 146(3):472-8.PMID:12947365. DOI:10.1016/S0002-8703(03)00308-9.
  61. Kopecky SL , Jopke T. The state of the clinical trials system today. Minn Med. 2003 Oct; 86(10):28-33. PMID:14621941.
  62. Peters RJG, Mehta SR, Fox KAA, Zhao F, Lewis BS, Kopecky SL , Diaz R, Commerford PJ, Valentin V, Yusuf S. Effects of aspirin dose when used alone or in combination with clopidogrel in patients with acute coronary syndromes - Observations from the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) study. Circulation. 2003 Oct 7; 108(14):1682-7.PMID:14504182.
  63. Brilakis ES, Wright RS, Kopecky SL , Mavrogiorgos NC, Reeder GS, Rihal CS, Gersh BJ, Williams BA, Clements IP. Association of the PURSUIT risk score with predischarge ejection fraction, angiographic severity of coronary artery disease, and mortality in a nonselected, community-based population with non-ST-elevation acute myocardial infarction. Am Heart J. 2003 Nov; 146(5):811-8.PMID:14597929.
  64. Bybee KA, Powell BD, Williams BA, Murphy JG, Kopecky SL , Wright RS. Superior short-term cholesterol control and achievement of the adult treatment panel III low-density lipoprotein goals with initiation of statin therapy by the time of hospital discharge following
  65. Bybee KA, Kopecky SL , Williams BA, Murphy JG, Wright RS. Reduced creatine kinase release with statin use at the time of myocardial infarction. Int J Cardiol. 2004 Sep; 96(3):461-6.PMID:15301900.
  66. Warrington KJ, Kent PD, Frye RL, Lymp JF, Kopecky SL , Goronzy JJ, Weyand CM. Rheumatoid arthritis is an independent risk factor for multi-vessel coronary artery disease: a case control study. Arthritis Res Ther. 2005; 7(5):R984-91. Epub 2005 Jun 29. PMID:16207339. PMCID:1257428. DOI:10.1186/ar1775.
  67. Bybee KA, Powell BD, Valeti U, Rosales AG, Kopecky SL , Mullany C, Wright RS. Preoperative aspirin therapy is associated with improved postoperative outcomes in patients undergoing coronary artery bypass grafting. Circulation. 2005 Aug 30; 112(9Suppl):I286-92.PMID:16159833. DOI:10.1161/CIRCULATIONAHA.104.522805.
  68. Camilleri M, Gamble GL, Kopecky SL , Wood MB, Hockema ML. Principles and process in the development of the Mayo Clinic's individual and institutional conflict of interest policy. Mayo Clin Proc. 2005 Oct; 80(10):1340-6.PMID:16212147. DOI:10.4065/80.10.1340.
  69. Osranek M, Bursi F, Bailey KR, Grossardt BR, Brown RD, Kopecky SL , Tsang TS, Seward JB. Left atrial volume predicts cardiovascular events in patients originally diagnosed with lone atrial fibrillation: three-decade follow-up. Eur Heart J. 2005 Dec;26(23):2556-61.PMID:16141257.
  70. Sato K, Niessner A, Kopecky SL , Frye RL, Goronzy JJ, Weyand CM. TRAIL-expressing T cells induce apoptosis of vascular smooth muscle cells in the atherosclerotic plaque. J
  71. Exp Med. 2006 Jan 23; 203(1):239-50. Epub 2006 Jan 17.PMID:16418392. PMCID:2118078. DOI:10.1084/jem.20051062.
  72. Zhang X, Niessner A, Nakajima T, Ma-Krupa W, Kopecky SL , Frye RL, Goronzy JJ, Weyand CM. Interleukin 12 induces T-cell recruitment into the atherosclerotic plaque. Circ Res. 2006 Mar 3; 98(4):524-31. Epub 2006 Jan 19.PMID:16424368. DOI:10.1161/01.RES.0000204452.46568.57.
  73. Benson H, Dusek JA, Sherwood JB, Lam P, Bethea CF, Carpenter W, Levitsky S, Hill PC, Clem DW, Jain MK, Drumel D, Kopecky SL , Mueller PS, Marek D, Rollins S, Hibberd PL. Study of the Therapeutic Effects of Intercessory Prayer (STEP) in cardiac bypass patients: a multicenter randomized trial of uncertainty and certainty of receiving intercessory prayer. Am Heart J. 2006 Apr; 151(4):934-42.PMID:16569567.DOI:10.1016/j.ahj.2005.05.028.
  74. Rodgers GP, Kopecky S . The future of cardiovascular biomarkers. Am Heart Hosp J. 2006 Summer; 4(3):228-31. PMID:16894263.
  75. Nigam A, Wright RS, Allison TG, Williams BA, Kopecky SL , Reeder GS, Murphy JG, Jaffe AS. Excess weight at time of presentation of myocardial infarction is associated with lower initial mortality risks but higher long-term risks including recurrent re-infarction and cardiac death. Int J Cardiol. 2006 Jun 16; 110(2):153-9. Epub 2005 Jul 25. PMID:16043245. DOI:10.1016/j.ijcard.2005.06.040.
  76. Kopecky SL . Effect of beta blockers, particularly carvedilol, on reducing the risk of events after acute myocardial infarction. Am J Cardiol. 2006 Oct 15; 98(8):1115-9. Epub 2006 Aug 31. PMID:17027583. DOI:10.1016/j.amjcard.2006.05.039.
  77. Atar D, Huber K, Rupprecht HJ, Kopecky SL , Schwitter J, Theek C, Brandl K, Henning R, Geudelin B. Rationale and design of the 'F.I.R.E.' study. A multicenter, double-blind, randomized, placebo-controlled study to measure the effect of FX06 (a fibrin-derivedpeptide Bbeta(15-42)) onischemia-reperfusion injury in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention. Cardiology. 2007; 108(2):117-23. Epub 2006 Oct 02.PMID:17019083. DOI:10.1159/000095982.
  78. Erbel C, Sato K, Meyer FB, Kopecky SL , Frye RL, Goronzy JJ, Weyand CM. Functional profile of activated dendritic cells in unstable atherosclerotic plaque. Basic Res Cardiol. 2007 Mar; 102(2):123-32. Epub 2006 Dec 01.PMID:17136419. DOI:10.1007/s00395-006-0636-x.
  79. Powell BD, Bybee KA, Valeti U, Thomas RJ, Kopecky SL , Mullany CJ, Wright RS. Influence of preoperative lipid-lowering therapy on postoperative outcome in patients undergoing coronary artery bypass grafting. Am J Cardiol. 2007 Mar 15; 99(6):785-9.Epub 2007 Jan 18. PMID:17350365. DOI:10.1016/j.amjcard.2006.10.036.
  80. Jahangir A, Lee V, Friedman PA, Trusty JM, Hodge DO, Kopecky SL , Packer DL, Hammill SC, Shen WK, Gersh BJ. Long-term progression and outcomes with aging in patients with lone atrial fibrillation: a 30-year follow-up study. Circulation. 2007 Jun 19;115(24):3050-6. Epub 2007 Jun 04. PMID:17548732. DOI:10.1161/CIRCULATIONAHA.106.644484.
  81. Aijaz B, Babuin L, Squires RW, Kopecky SL , Johnson BD, Thomas RJ, Allison TG.Long-term mortality with multiple treadmill exercise test abnormalities: comparison between patients with and without cardiovascular disease. Am Heart J. 2008 Oct; 156(4):783-9. Epub 2008 Jul 11.PMID:18926161. DOI:10.1016/j.ahj.2008.05.026.
  82.  Al Badarin FJ, Kullo IJ, Kopecky SL , Thomas RJ. Impact of ezetimibe on atherosclerosis: is the jury still out? Mayo Clin Proc. 2009 Apr; 84(4):353-61. PMID:19339654. PMCID:2665981. DOI:10.1016/S0025-6196(11)60545-4.
  83. Kopecky SL , Litin SC. Clinical pearls in cardiology. Mayo Clin Proc. 2010 May;85(5):473-8. PMID:20435840. PMCID:2861977. DOI:10.4065/mcp.2010.0030.
  84. Cullen MW, Reeder GS, Farkouh ME, Kopecky SL , Smars PA, Behrenbeck TR, Allison TG. Outcomes in patients with chest pain evaluated in a chest pain unit: the chest pain evaluation in the emergency room study cohort. Am Heart J. 2011 May; 161(5):871-7. PMID:21570516. DOI:10.1016/j.ahj.2011.02.008.
  85. Vickers KS, Nies MA, Dierkhising RA, Salandy SW, Jumean M, Squires RW, Thomas RJ, Kopecky SL . Exercise DVD improves exercise expectations in cardiovascular outpatients. Am J Health Behav. 2011 May; 35(3):305-17.PMID:21683020.
  86. Gupta BP, Murad MH, Clifton MM, Prokop L, Nehra A, Kopecky SL . The effect of lifestyle modification and cardiovascular risk factor reduction on erectile dysfunction: a systematic review and meta-analysis. Arch Intern Med. 2011 Nov 14; 171(20):1797-803. Epub 2011 Sep 12. PMID:21911624. DOI:10.1001/archinternmed.2011.440.
  87. Dhoble A, Sarano ME, Kopecky SL , Thomas RJ, Hayes CL, Allison TG. Safety ofsymptom-limited cardiopulmonary exercise testing in patients with aortic stenosis. Am J Med. 2012 Jul; 125(7):704-8. Epub 2012 May 03. PMID:22560172. DOI:10.1016/j.amjmed.2012.01.012.
  88. Kopecky S . New anticoagulants for stroke prophylaxis in atrial fibrillation: assessing the impact on medication adherence. Am J Cardiovasc Drugs. 2012 Oct 1; 12(5):287-94. PMID:22946769. DOI:10.2165/11634130-000000000-00000.
  89. Heaney RP, Kopecky S , Maki KC, Hathcock J, Mackay D, Wallace TC. A review of calcium supplements and cardiovascular disease risk. Adv Nutr. 2012 Nov; 3(6):763-71. Epub 2012 Nov 01. PMID:23153730. PMCID:3648700. DOI:10.3945/an.112.002899.
  90. Zysek V, Spoon J, Kopecky S . Mayo Clinic: Management of patients with statin intolerance. Clinical Lipidology. 2013; 8(5):541-9.
  91. Konecny T, Nehra A, Pellikka PA, Ommen SR, Kopecky SL . Stress imaging in men with hypertrophic cardiomyopathy and erectile dysfunction. Journal of Men's Health. 2013; 10(4):152-3.      
  92. Killu AM, Wright RS, Kopecky SL . Questions and answers on proper peri-operative managementof antiplatelet therapy after coronary stent implantation to prevent stent
  93. Abudiab M, Aijaz B, Konecny T, Kopecky SL , Squires RW, Thomas RJ, Allison TG. Use of functional aerobic capacity based on stress testing to predict outcomes in normal, overweight, and obese patients. Mayo Clin Proc. 2013 Dec; 88(12):1427-34. PMID:24290116. DOI:10.1016/j.mayocp.2013.10.013.
  94. Dhoble A, Lahr BD, Allison TG, Kopecky SL . Cardiopulmonary fitness and heart rate recovery as predictors of mortality in a referral population. J Am Heart Assoc. 2014; 3(2):e000559. Epub 2014 Mar 24.PMID:24663334. DOI:10.1161/JAHA.113.000559.
  95. Fenstad ER, Anavekar NS, Williamson E, Deschamps C, Kopecky SL . Twist and shout: acute right ventricular failure secondary to cardiac herniation and pulmonary artery compression. Circulation. 2014 Apr 1; 129(13):e409-12. PMID:24687648. DOI:10.1161/CIRCULATIONAHA.113.003647.
  96. Rosenson RS, Baker SK, Jacobson TA, Kopecky SL , Parker BA. An assessment by the Statin Muscle Safety Task Force: 2014 update. J Clin Lipidol. 2014 May-Jun; 8(3Suppl):S58-71. PMID:24793443. DOI:10.1016/j.jacl.2014.03.004.
  97. 96.Dhoble A, Enriquez-Sarano M, Kopecky SL , Abdelmoneim SS, Cruz P, Thomas RJ, Allison TG. Cardiopulmonary responses to exercise and its utility in patients with aortic
  98. stenosis. Am J Cardiol. 2014 May 15; 113(10):1711-6. Epub 2014 Mar 2PMID:24698467. DOI:10.1016/j.amjcard.2014.02.027.
  99. Thaden JJ, McCully RB, Kopecky SL , Allison TG. Echocardiographic determinants of peak aerobic capacity and breathing efficiency in patients with undifferentiated dyspnea. Am J Cardiol. 2014 Aug 1; 114(3):473-8. Epub 2014 May 17. PMID:24948490. DOI:10.1016/j.amjcard.2014.04.054.
  100. Kullo IJ, Trejo-Gutierrez JF, Lopez-Jimenez F, Thomas RJ, Allison TG, Mulvagh SL,Arruda-Olson AM, Hayes SN, Pollak AW,Kopecky SL , Hurst RT. A Perspective on the New American College of Cardiology/American Heart Association Guidelines for Cardiovascular Risk Assessment. Mayo Clin Proc. 2014 Sep; 89(9):1244-56. Epub 2014 Aug 12. PMID:25131696. DOI:10.1016/j.mayocp.2014.06.018.
  101. Lopez-Jimenez F, Simha V, Thomas RJ, Allison TG, Basu A, Fernandes R, Hurst RT,Kopecky SL, Kullo IJ, Mulvagh SL, Thompson WG, Trejo-Gutierrez JF, Wright RS. A Summary and Critical Assessment of the 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Disease Risk in Adults: Filling the Gaps. Mayo Clin Proc. 2014 Sep; 89(9):1257-78. Epub 2014 Aug 12. PMID:25131697. DOI:10.1016/j.mayocp.2014.06.016.
  102. Dhoble A, Lahr BD, Allison TG, Bailey KR, Thomas RJ, Lopez-Jimenez F, Kullo IJ, Gupta B, Kopecky SL . Predicting long-term cardiovascular risk using the mayo clinic cardiovascular risk score in a referral population. Am J Cardiol. 2014 Sep 1; 114(5):704-10.Epub 2014 Jun 19 PMID:25052544. DOI:10.1016/j.amjcard.2014.05.061.
Non-Indexed Peer-reviewed Articles
  1. Kopecky SL . The role of anticoagulation in atrial fibrillation. Cardio 87-97 1990.
  2. Daly R, Ebling W, Pieniaszek H, Cain V, Kopecky S , Murphy J. Roxifiban, a new oral IIb/IIIa glycoprotein receptor antagonist, in patients with coronary artery disease. Lancet. 1999 Jun 26; 353(Suppl 3):49.PMID:10023964.
  3. Kopecky SLTreatmentof Acute MI. Institute for Clinical Systems Improvement. Postgraduate Medicine. 1999 Nov; 106(6):57-58.
  4. Holland AE, Wright RS, Kopecky SL . Educating Investigative Sites: Bridging the Knowledge Gap in Clinical Trials. Clinical Researcher. 2002; 2(6):14-8.
  5. Lymp JF, Kopecky SL . Interim monitoring: ensuring safety and efficacy in clinical trials. Clinical Researcher. 2004 Mar; 2(3):14-7.
  6. Gupta B, Kopecky SL . Childhood obesity: Implication for adult health behaviors The Global Journal of Health and Physical Education Pedagogy. 2012; 1:2-14.

Abstracts

  1. Kopecky SL , Miller W. Effects of methylprednisolone sodium succinate on monocrotaline induced pulmonary edema in dogs. Texas Thoracic Society Scientific Session. 1980 1980 Apr.
  2. Kopecky SL , Gersh BJ, McGoon MD, Holmes DR Jr, Whisnant JP, Frye RL. The natural history of idiopathic 'lone' atrial fibrillation: a three-decade population-based study. Circulation. 1985 Oct; 72(PART 2):III-1.
  3. Kopecky SL , Kazmier KJ, Pluth JR, Reeder GS. Cardiac fibroma mimicking hypertrophic cardiomyopahty. American College of Chest Phyisicans Affiliated Forum, 1985 Nov, Chest.
  4. Kopecky SL , Gibbons RJ, Hollier LH. Preoperative supine exercise radionuclide angiogram predicts perioperative cardiovascular events in vascular surgery. J Am Coll Cardiol. 1986 Feb; 7:226A.
  5. Kopecky SL , Gersh BJ, McGoon MD, Mair DD, Porter, C-BJ, Ilstrup D, Mcgoon DC, Danielson GK. Long-term prognosis of patients undergoing surgical repair of isolated pulmonary valve stenosis: a 20 to 30 year follow up. J Am Coll Cardiol. 1988; 11(Suppl A):69A.
  6. Roger VL, Kopecky SL , Gibbons RJ, Puetz PA, Hench VS, Zinsmeister AR, Gersh BJ. Exercise radionuclide angiography after non-Q-wave myocardial infarction. J Am Coll Cardiol. 1988 Feb; 11(Suppl A):216A.
  7. Kopecky SL , Gersh BJ, McGoon MD, Whisnant JP, Ilstrup DM. Lone atrial fibrillation in the elderly: a population-based long-term study. (Abstract 1625). Circulation. 1989 Oct;80(Suppl):II-409.
  8. Murphy JG, Gersh BJ, Kopecky SL , McGoon MD, Mair DD, Porter CJ, McGoon DD, Kirklin JW, Danielson GK. Sudden death in repaired congenital heart disease: follow-upat 30 years in 610 patients (Abstracts). Circulation 82:III-716, 1990.
  9. Holmes DR Jr, Lapeyre AC III, Schwartz RS, Kopecky SL , Tilbury RT, Garratt KN. Thrombectomy of occluded coronary arteries: an initial clinical experience. American Heart Assoc. 1990; 82: III-623.
  10. Tilbury RT, Bresnahan JF, Bell MR, Vliestra RE, Kopecky SL , Holmes DR Jr. Temporary pacemaker placement during percutaneous transluminal coronary angioplasty. Cathet Cardiovasc Diagn. 1990; 19:297.
  11. Holmes DR Jr, Schaff HV, Hammes LN, Mock MB, Kopecky SL . Effect of percutaneous transluminal coronary angioplasty on surgery for single vessel coronary artery disease. J Am Coll Cardiol. 1990 Feb; 15(Suppl A):179A.
  12. Murphy JG, Gersh BJ, SteckelbergJM, Kopecky SL , Mair DD, Kirklin JW, Danielson GK, Wilson WR. Risk of late endocarditis following congenital heart repair:30-year follow-up in 610 patients. J Am Coll Cardiol. 1991 Feb; 17(Suppl A):135A.
  13. Holmes DR Jr, Kopecky SL . Acute infarction therapies. Rochester, Minnesota, Clinical Reviews. 1993; 151.
  14. Kopecky SL . Atrial fibrillation--management and anticoagulants. Rochester, Minnesota, Clinical Reviews. 1993; 21-3.
  15. Nobrega TP, Kopecky SL , Gersh BJ, et al. Coronary angiography in the elderly: utilization rates and revascularization procedures in a geographically defined population. Society for Cardiac Angiography and Interventions, 16th Annual Meeting, May 18-22,1993.
  16. Kopecky SL , Reeder GS, Reiner JS, Lundergan CF, Razavi A, McCormick D, Coyne KS, Jesse R, Ross AM. Resolution of coronary thrombus over time: a report from the GUSTO angiographic trial. J Am Coll Cardiol. 23:244A., 1994.
  17. Reiner JS, Lundergan CF, Kopecky SL , Hodgson J, Pilcher G, van de Brand M, Fung A, Ross AM. Resolution of conorary thrombus over time: A report from the GUSTO Angiographic Trial. J Am Coll Cardiol. 23:244A, 1994.
  18. Kopecky SL , Siska MJ, Jurek JA, Gudgell SF, Meloy TD, Fischer DR, Reeder GS. Method of reducing emergency room time to treatment for acute myocardial infarction. (Abstract 956-115). J Am Coll Cardiol. 1995 Feb; (Special Issue):206A.
  19. Wright RS, Rogers Morian R, Wallace DL, Schwartz RS, Chesebro JH, Kopecky SL . Is stenosis severity predictive of future coronary artery occlusion in a paired angiographic study? (Abstract 1016-43). J Am Coll Cardiol. 1996 Feb; 27(Suppl A):370A.
  20. Farkouh ME, Gabriel SE, Evans RW, Smars PA, Kopecky SL , Reeder GS, Traverse KA, Zinsmeister AR. A population-based evaluation of the ahcpr guideline for management of unstable angina: the Olmsted county acute chest pain study. (Abstract 0057). Circulation. 1996 Oct 15; 94(8 Suppl):I-10.
  21. Thompson RC, Kopecky SL , Mullany CJ, Grill D, Gray DT. Comparison of percutaneous transluminal coronary angioplasty and bypass surgery in the elderly residents of Olmstead county, Mn. (Abstract 3140). Circulation. 1996 Oct 15; 94(8Suppl):I-536-I-537.
  22. O'Connor CM, Fisher M, O'Gara P, Sutton J, Kopecky S , Harrington RA, Daly R, DeMets D, Fuster V, et al. The importance of aspirin dose in the protection of non-hemorrhagicstroke following acute myocardial infarction: insights from the Coumadin Aspirin Reinfarction Study (CARS). (Abstract 0461). Circulation. 1996 Oct 15; 94(8Suppl):I-80-I-81.
  23. Harrington RA, Berkowtiz SD, McDougal, Jett L, Langer A, O'Gara PT, Kopecky SL , Sutton J, Hainer J, Lee R, Fisher M, O, Connor CM. Level of anticoagulation achieved in myocardial infarction patients following chronic administration of fixed, low-dose Warfain therapy: Results from the Coumadin Aspirin Reinfarction Study (CARS). J AM Coll Cardiol. Suppl 376A, 1997.
  24. Yacyshyn VJ, Kopecky SL , Laham CL, Schaff HV, Naessens JM, Cox JL, Johnstone DE. Comparison of coronary bypass grafting in comparable defined geographic populations in Canada/United States. J Am Coll Cardiol. 1997; 29(2 Suppl A):310A.
  25. Kopecky SL , Schaff HV, Hammill SC, Cragun T, Dearani JA, Bailey KR. Decreased incidence of stroke in atrial fibrillation patients after a maze procedure. (Abstract 931-81). J Am Coll Cardiol. 1997 Feb; 29(2 Suppl A):105A.
  26. Kopecky SL, Erwin JP,Wright RS. Incidence of prodromal symptoms in patients with acute myocardial infarction in a defined geographic population. (Abstract 902-2). J Am Coll Cardiol. 1997 Feb; 29(2 Suppl A):13A.
  27. Farkouh ME, Smars PA, Reeder GS, Evans RW, Zinsmeister AR, Meloy TD, Kopecky SL , Allen MR, Allison T, Gabriel SE. The effectiveness of a chest pain observation unit (cpu) in emergency triage of patients at intermediate risk for coronary events: the Cheer trial (chest pain evaluation in the ER). (abstract 756-5). J Am Coll Cardiol. 1997 Feb; 29(2 Suppl A):211A.
  28. Wright RS, Nunez BD, Reeder GS, Kopecky SL , Garratt KN. Intracoronary stent therapy enhances luminal diameter and reduces residual stenosis in a subset of patients with acute myocardial infarction. (Abstract 971-11). J Am Coll Cardiol. 1997 Feb; 29(2 Suppl A):236A.
  29. Roger VL, Gabriel SE, Reeder GS, Smars PA, Kopecky SL , Traverse KA, Zinsmeister AR, Farkouh ME. Evaluation of chest pain in the emergency room: is there gender bias? A population based study in Olmsted county, Minnesota. (923-136). J Am Coll Cardiol. 1997 Feb; 29(2 Suppl A):49A.
  30. Srivatsa SS, Hasdai D, Criger DA, Vassanelli C, Policilinico V, Kopecky SL , Garratt KN. Diabetic status and reperfusion strategy for acute myocardial infarction. (Abstract 2237). Circulation. 1997 Oct 21; 96(8 Suppl):I-399.
  31. Handa N, Schaff HV, Anderson BJ, Kopecky SL . Early results of Cox-maze procedure combined with mitral valve repair. (Abstract 4103). Circulation. 1997 Oct 21; 96(8Suppl):I-731.
  32. Jahangir A, Munger TM, Shen WK, Kopecky SL . Atrial fibrillation during acute myocardial infarction is associated with increased in-hospital mortality, re-infarction and stroke in a geographically defined population Arch d Mal Coeur Vaisseaux. 1998;91:311.
  33. Liuzzo G, Kopecky SL , Cornwell K, Frye RL, Goronzy JJ, Weyand CM. Expansion of unusual CD4+ T lymphocytes as a prognostic indicator of short- and long-term outcome in ischemic heart disease. American College of Cardiology 48th Annual Scientific Session, 1998
  34. Liuzzo G, Kopecky SL , Goronzy JJ, Cornwell K, Maseri A, Frye RL, Weyand CM. Disease specific patterns of cytokine production by T-lymphocytes in coronary atherosclerosis: evidence for a role of infectious agents in the pathogenesis of unstable angina? J Am Coll Cardiol. 1998; 31(2 Suppl A):187A.
  35. Grantham JA, Hasdai D, Kopecky SL , Holmes DR. Platelet glycoprotein IIB/IIIA receptor inhibition during PTCA for acute MI: a retrospective analysis of in hospital and one year outcome. J Am Coll Cardiol. 1998; 31(2 Suppl A):231A.
  36. Sgura FA, Kopecky SL , Grill JP, Wright RS, Reeder GS. Primary PTCA in acute myocardial infarction is associated with reduced length of stay in a defined geographic population in Olmsted county, Minnesota. (Abstract tct-248). Am J Cardiol. 1998 Oct; 82(Suppl 7A):91S.
  37. Wright RS, Sgura FA, Reeder GS, Rihal CS, Miller WL, Kopecky SL . Effect of treatment with revascularization on in-hospital mortality, reinfarction and stroke in non-Q-wavemyocardial infarction in a defined geographic population. (Abstract tct-247). Am J Cardiol. 1998 Oct; 82(Suppl 7A):91S.
  38. Sgura FA, Kopecky SL , Grill JP, Gibbons RJ. Exercise workload capacity identifies patients at low risk for perioperative cardiovascular events and long-term mortality. Circulation. 1998 Oct 27; 98(17S):157I.
  39. Liuzzo G, GoronzyJJ, KopeckySL , Cornwell KB, Frye RL, Weyand CM. T cell function in unstable angina: increased interferon-G production by unusual T lymphocytes. Circulation. 1998 Oct 27; 98(17S):171I.
  40. Kopecky SL , Feldman RL, Breisblatt WM, Clements IP, Gibbons RJ, Yu AS. Safety of Hu23F2G as ancillary therapy to direct PTCA in patients with acute myocardial infarction: the festival study. Circulation. 1998 Oct 27; 98(17S):280I.
  41. Wright RS, Al Suwaidi JM, Brady PA, Terzic A, Barsness GW, Kopecky SL .Insulin-treated diabetes mellitus is associated with an increased risk of inhospital andsix-month mortality in acute coronary syndromes. Circulation. 1998 Oct 27; 98(17S):555I.
  42. Moore AG, Wright RS, Kopecky SL , Lapeyre ACI, Grill JP, Rumberger JA. Effect of smoking status on in-hospital mortality and long-term survival in acute myocardial infarction patients from a defined geographic population. Circulation. 1998 Oct 27; 98(17S):811I.
  43. Jahangir A, Shen WK, Munger TM, Kopecky SL . Atrial fibrillation during acute myocardial infarction is associated with increased in-hospital mortality, re-infarction and stroke in a geographically defined population. Asian Cardiovasc Thorac Annals. 1999.
  44. Atwal D, Genter JF, Kopecky SL , Weston S, Bailey KT, Hammill SC. Increased body mass index and obstructive sleep apnea signs are risk factors for atrial fibrillation. J Am Coll Cardiol. 1999 Feb; 33(2 Suppl A):128A.
  45. Mathew V, Wright RS, Oh JK, Sinak LJ, Tilbury RT, Grill JP, Reeder GS, Kopecky SL . Treatment with percutaneous transluminal coronary angioplasty may reduce the rate ofQ-wave myocardial infarction compared to thrombolysis in acute ST elevation myocardial infarction. J Am Coll Cardiol. 1999 Feb; 33(2 Suppl A):339A.
  46. Liuzzo G, Kopecky SL , Cornwell K, Frye RL, Goronzy JJ, Weyand CM. Expansion of unusual CD4+ T lymphocytes as a prognostic indicator of short- and long-term outcome in ischemic heart disease. J Am Coll Cardiol. 1999 Feb; 33(2 Suppl A):362A.
  47. Haley JH, Suh WW, Pellikka PA, Wright RS, Bell MR, Reeder GS, Grill JP, Kopecky SL . Gender remains a powerful predictor of increased mortality in acute myocardial infarction in a defined community population. J Am Coll Cardiol. 1999 Feb; 33(2 Suppl A):365A.
  48. Miller WL, Wright RS, Asirvatham S, Sgura F, Grill JP, Kopecky SL . New Q-wavedevelopment following acute myocardial infarction does not predict increased short orlong-term mortality. Eur Heart J. 1999 Aug; 20(ABSTR. Suppl):243.
  49. Mathew V, Farkouh ME, Reeder GS, Rihal CS, Kopecky SL , Grill DE, Chesebro JH, Gersh BJ, Holmes DR Jr. Early angiography in the evaluation of patients presenting with unstable angina. Eur Heart J. 1999 Aug; 20(ABSTR. Suppl):277.
  50. Kopecky S , Midei M, Kellett M, Butler J, Fromell G, Holland AE, Lester D, Tipping D, Gibbons R, Lee S. Initial report of AMP579 delivery for myocardial infarction reduction (ADMIRE). Eur Heart J. 1999 Aug; 20(ABSTR. Suppl):53.
  51. Sgura FA, Wright RS, Grill JP, Reeder GS, Kopecky SL . Reduction in length of stay for acute myocardial infarction: lessons learned over 10 years in a defined geographic population. Eur Heart J. 1999 Aug; 20(ABSTR. Suppl):546.
  52. Gumina RJ, Wright RS, Murphy JG, Miller WL, Grill JP, Kopecky SL . In-hospital andlong-term outcome of right ventricular infarction in a defined community population: the Mayo clinic coronary care unit experience. Eur Heart J. 1999 Aug; 20(Abstract Suppl):478.
  53. Aviles RJ, KopeckySL, Lobl JK, et al. Admire trial. Mayo Research Forum. 1999 Oct 1.
  54. Liuzzo G, Goronzy JJ, Yang H, Kopecky SL , Holmes DR, Frye RL, Weyand CM. Monoclonal T Cell Proliferation in Patients with Unstable Angina Circulation, 1999 Nov 2; (18 Supple): I-648
  55. Kopecky SL , Midei MG, Kellett MA, Butler JF, Holland AE, Zannikos PN, Tipping DM, Gibbons RJ, Lee SW, Bell MR. Report of AMP579 delivery for myocardial infarction reduction (ADMIRE). Circulation. 1999 Nov 2; 100(18 Suppl):I.651.
  56. Mathew V, Farkouh ME, Reeder GS, Rihal CS, Kopecky SL , Chesebro JH, Gersh BJ, Holmes DR Jr. Early angiography in the evaluation of patients presenting with unstable angina. Circulation. 1999 Nov 2; 100(18 suppl):I-103.
  57. Wright RS, Kopecky SL , Barsness GW, Tuttle RH. Impact of diabetes mellitus on outcome in non-ST elevation myocardial infarction and unstable angina: is there a benefit from treatment with eptifibatide. Circulation. 1999 Nov 2; 100(18 Suppl):I.640.
  58. Bybee KA, Wright RS, Williams BA, Grill JP, Kopecky SL . Is use of a statin agent at the time of presentation for acute myocardial infarction associated with a favorable outcome? J Am Coll Cardiol. 2000 Feb; 35(2 Suppl A):314A-315A.
  59. Barsness GW, Wright RS, Gersh BJ, Rihal CS, Garratt KN, Reeder GS, Williams BA, Dvorak DL, Kopecky SL . Early ACE inhibitor treatment is associated with improvedshort-term survival in diabetics after acute myocardial infarction. J Am Coll Cardiol. 2000 Feb; 35(2 Suppl A):346A.
  60. Every NR, Hochman J, Becker R, Kopecky SL , Cannon C. Critical Care Pathways: A Review. Circulation. 101(4):461, 2000 Feb 1.
  61. Brilakis ES, Kopecky SL , Gersh BJ, Clements IP. QRS Duration *100 ms in the Absence of Left or Right Bundle Branch Block is an Early Predictor of Survival in Non-ST Elevation Acute Myocardial Infarction. European Society of Cardiology 22nd Annual Congress, 2000 Aug.
  62. Gussak I, Kopecky SL , Bjerregaard P. Familial short QT interval syndrome. Eur Heart J. 2000 Aug-Sep; 21(Abstract Suppl):451.
  63. Brilakis ES, Kopecky SL , Gersh BJ, Clements IP. QRS duration greater than or equal to100ms in the absence of left or right bundle branch block is an early predictor of survival in non-ST- elevation acute myocardial infarction. Eur Heart J. 2000 Aug-Sep;21(Abstract Suppl):503.
  64. Gussak I, Quiles C, Wright RS, Williams B, Holland A, Ramsey K, Bell MR, Gibbons RJ,Kopecky SL . Admission ECG criteria for the predictive assessment of the size of acuteST-segment elevation non-Q-wave inferior myocardial infarction. Eur Heart J. 2000Aug-Sep; 21(Abstract Suppl):519.
  65. Gussak I, Murphy J, Daly R, Wright RS, Cornwell K, Williams B, Wilcox RA, Kopecky SL. The use of roxifiban, a novel oral IIb/IIIa platelet inhibitor, in patients with stable coronary artery disease. Eur Heart J. 2000 Aug-Sep; 21(Abstract Suppl):648.
  66. Temesgen Z, Liuzzo G, Kopecky SL , Goronzy JJ, Frye RL, Gussak I, Weyand CM. Chronic stimulation by a shared antigen underlies the clonal expansion of CD4+CD28null T-cells involved in acute coronary event. IV European Chlamydia Congress, Helsinki, Finland, August 20-23, 2000
  67. Schulte S, Goronzy JJ, Kopecky SL , Holmes DR, Frye RL, Weyand CM. Cytotoxic CD4+CD28- T cells in plaque instability. Circulation. 2000 Oct 31; 102(18 Suppl):II.253.
  68. Bybee KA, WrightRS, PowellBD, Williams BA, Vinar JT, Kopecky SL . Differential benefit from treatment with a statin agent at hospital discharge in non-ST elevation MI compared to ST elevation MI. Circulation. 2000 Oct 31; 102(18 Suppl):II.614.
  69. Tedesco JV, Wright RS, Reeder GS, Kopecky SL , Dvorak D, Williams BA, Miller WL for the Coronary Care Unit Group. Cardiogenic shock and mortality in diabetics from acommunity-based population. J Heart Dis. 2001;2(1):90.
  70. Tedesco JV, Wright RS, Reeder GS, Kopecky SL , Dvorak D, Williams BA, Miller WL for the Coronary Care Unit Group. Cardiogenic shock and mortality in an elderlycommunity-based population. J Heart Dis. 2001;2(1):45.
  71. Warrington KJ, Kent PD, Nakajima T, Kopecky SL , Frye RL, Lymp JF, Goronzy JJ, Weyand CM. Rheumatoid arthritis is an independent risk factor for accelerated coronary artery disease (Abstract #1955). Arthritis Rheum. 2001; 44(Suppl):S378.
  72. Mondick JT, Fossler MJ, Sy SKB, Ebling WF, Garner DM, Kornhauser DM, Daly RN,Kopecky SL, Pieniaszek HJ Jr. Comparative pharmacokinetics (PK) and pharmacodynamice (PD) of Roxifiban, a potent and specific platelet GPIIb/IIIa antagonist in patients with chronic stable coronary artery disease (CAD) and in healthy subjects. J Clin Pharmacol. 2001; 41(9):1023.
  73. Brilakis ES, Mavrogiorgos NC, Kopecky SL , Gersh BJ, Williams B, Clements IP. Mild QRS prolongation is associated with increased mortality in non-ST elevation acute myocardial infarction. (Abstract Athens-04). J Invasive Cardiol. 2001; 13:475.
  74. Wright RS, Miller WL, Gussak I, Dvorak DL, Aufderheide TP, Haley JH, Kopecky SL , Reeder GS, Hammill SC. Women with acute anterior myocardial infarction have less precordial ST elevation than men independent of age of presentation. J Am Coll Cardiol. 2001 Feb; 37(2 Suppl A):361A.
  75. Brilakis ES, Kopecky SL , Williams BA, Vinar J, Clements IP. Use of the PURSUIT risk score can provide accurate early risk stratification in a nonselected, community-basedpopulation with non-ST elevation acute myocardial infarction. J Am Coll Cardiol. 2001 Feb; 37(2 Supplement A):344A.
  76. Nakajima T, Schulte S, Frye RL, Kopecky SL , Goronzy JJ, Weyand CM. T cell effector functions in acute coronary syndromes. FASEB J. 2001 Mar 7; 15(4):A680.
  77. Miller WL, Sgura FA, Kopecky SL , Asirvatham SJ, Williams BA, Wright RS, Reeder GS. Pattern of presenting electrocardiograms in acute myocardial infarction predict short andlong-term mortality in a community-based population. Eur Heart J. 2001 Sep; 22(Abstract Suppl):111.
  78. Brilakis ES, Wright RS, Kopecky SL , Reeder GS, Williams BA, Miller WL, Mavrogiorgos N. Bundle-branch block as a predictor of long-term survival after acute myocardial infarction: Results from a community-based population. Eur Heart J. 2001 Sep; 22(Abstract Supplement):71.
  79. Hylek E, Stewart S, Gilchrist K, Kopecky S . A national registry to improve outcomes in anticoagulation. (Abstract B4). J Thromb Thrombolysis. 2001 Sep; 12(1):105.
  80. Aviles RJ, Kopecky SL , Tolzmann JM, McDonald F, Ballman K, Askari AT,Harker-Murray A, Scott C, Lauer MS, Wright RS, Jaffe AS. Modest elevations of cardiac troponin I predict short and long-term mortality in patients with Braunwald class IIIB unstable angina. Circulation 104 (Supplement II):II.707, October, 2001.
  81. Wright RS, Jaffe AS, Miller WL, Murphy JG, Albright R, Dvorak D, Williams BA, Kopecky SL , Reeder GS. Renal dysfunction and acute myocardial infarction: A gradient of risk. Circulation. 2001 Oct 23; 104(17 Suppl):II.379.
  82. Gumina RJ,Wright RS,Murphy JG, Miller WL, Williams BA, Reeder GS, Kopecky SL . Prognostic implications of TIMI risk score in patients with right ventricular infarction. Circulation. 2001 Oct 23; 104(17 Suppl):II.380.
  83. Brilakis ES, Mavrogiorgos NC, Kopecky SL , Wright RS, Reeder GS, Gersh BJ, Williams BA, Clements IP. Validation of the TIMI risk score for ST-elevation acute myocardial infarction in a community-based coronary care unit registry. Circulation. 2001 Oct 23; 104(Suppl II):II-380.
  84. Brilakis ES, Mavrogiorgos NC, Kopecky SL , Wright RS, Reeder GS, Gersh BJ, Williams BA, Clements IP. Use of the PURSUIT risk score for predicting late mortality in anon-selected, community-based population with both ST-elevation and non-ST elevation acute myocardial infarction. (Abstract 3286). Circulation. 2001 Oct 23; 104(Suppl II):II-696.
  85. Oyen LJ, Murray MJ, John D, Decker PA, Messina T, Worrall CL, Kopecky SL , Bower TC. A pilot study of epidural analgesia & anesthesia and cardiac morbidity following abdominal vascular operations. (Abstract 603/S271). Crit Care Med. 2001 Dec; 29(12 Suppl.):A182.
  86. Decker WW, Prina LD, Smars PA, Boggust AJ, Zinsmeister AR, Kopecky SL . Surveillance continue par un ECG à 12 dérivations dans une "Unité de la douleur thoracique" aux urgences. JEUR. 15:P29, 2002.
  87. Decker WW, Prina LD, Smars PA, Boggust AJ, Zinsmeister AR, Kopecky SL . Continuous 12-lead electrocardiographic monitoring in an emergency department chest pain unit: an assessment of potential clinical impact. Forum Med Suisse. Suppl.8:A250, 2002.
  88. Gami AS, Wright RS, Hayes SE, Kopecky SL . Hormone replacement therapy and risk of myocardial infarction in women with diabetes. J Am Coll Cardiol. 2002 Mar 6; 39(5 Suppl A):238A-239A.
  89. Nakajima T, Abbas AE, Schultz S, Warrington KJ, Kopecky SL , Frye RL, Goronzy JJ, Weyand CM. IL-12 mediated activation of cytotoxic CD4 T cells in acute coronary syndromes. J Am Coll Cardiol. 2002 Mar 6; 39(5 Suppl A):263A.
  90. Wright RS, Murphy JG, Herzog CA, Reeder GS, Miller WL, Kopecky SL , Albright RC, Williams BA, Jaffe AS. Acute myocardial infarction and renal failure: Impact of treatment on short and long-term survival. J Am Coll Cardiol. 2002 Mar 6; 39(5 Suppl A):318A.
  91. Deb A, Wright RS, Williams BA, Barsness GW, Kopecky SL . Do observed gender differences in acute myocardial infarction outcome exist among diabetic patients? J Am Coll Cardiol. 39(9 Suppl B):2702, 2002 May.
  92. Wu LA, Tan SL, Wright RS, Kopecky SL , Burritt MF, Santrach PJ, Frye RL, Liu J. Prognostic value of the erythrocyte sedimentation rate in patients with unstable angina. Archives of Pathology & Laboratory Medicine. 2002 Jul; 126(7):772.
  93. Wright RS, Bybee KA, Powell BD, Williams BA, Rosales AG, Holmes DR, Kopecky SL , Murphy JG. Statin therapy within the initial 24 hours of acute myocardial infarction: Insight into why mortality is reduced. Eur Heart J. 2002 Aug-Sep; 23(Abstract Supplement):422.
  94. Brilakis ES, Wright RS, Kopecky SL , Reeder GS, Rihal CS, Gersh BJ, Williams BA, Clements IP. The PURSUIT Risk Score Correlates With Ejection Fraction and angiographic findings in non-ST elevation acute myocardial infarction (Abstract 3680). Eur Heart J. 2002 Aug/Sep; 23(Suppl):719.
  95. Zhang X, Nakajima T, Kopecky SL , Frye RL, Goronzy JJ, Weyand CM. Exposure to theproinflammatory cytokine IL-12 promotes tissue invasiveness of plaque-infiltrating CD4 T cells. Circulation.2002 Nov5; 106(19 Suppl):II-244.
  96. Wright RS, Reeder GS, Murphy JG, Miller WL, Williams BA, Kopecky SL , Jaffe A. Benefit of reperfusion in patients with mild but not severe renal failure and acute myocardial infarction. Circulation. 2002 Nov 5; 106(19 Suppl):II-630.
  97. Saint-Jacques H, Kandzari DE, Hellkamp AS, O'Connor CM, Califf R, Vorchheimer DA, Fuster V, Langer A, Kopecky SL , O'Gara PT, Harrington RA, et al. Demographic and clinical predictors of excessive anticoagulation following initiation of warfarin therapy. J Am Coll Cardiol. 2003 Mar; 41(6 Suppl A):226A.
  98. Kopecky SL , Regan S, McClelland R, Stewart S, Hylek EM. National trends of lower target intensity among elderly patients taking warfarin: The anticoagulation consortium to improve outcomes nationally (ACTION) Study. J Am Coll Cardiol. 2003 Mar 19; 41(6 Suppl A):153A.
  99. Nigam A, Murphy JG, Squires RW, Allison TG, Hensrud DD, Williams BA, Kopecky SL , Wright RS. Increased body mass index is associated with better short-but not long-termoutcome following acute myocardial infarction despite an increased risk of recurrent events. J Am Coll Cardiol. 2003 Mar 19; 41(6 Suppl A):533A-534A.
  100. Bursi F, Osranek M, Bailey K, Kopecky S , Seward JB. Left atrial volume is a predictor of cardiovascular events in lone atrial fibrillation: A long-term follow-up study. Eur Heart J. 2003 Aug-Sep; 24(Abstract Supplement):279.
  101. Murphy JG, Wright S, Nigam A, Miller WL, Allison TG, Kopecky SL , Jaffe AS. Myocardial infarcts in the obese differ significantly from infarcts in the non-obese patient: Management and prognosis implications. Eur Heart J. 2003 Aug-Sep; 24(Abstract Supplement):318.
  102. Sato K, Kopecky SL , Frye RL, Gores GJ, Higuchi H, Goronzy JJ, Weyand CM.T-cell-mediated injury of vascular smooth muscle cells in acute coronary syndromes: A role for the death receptor ligand Apo2L/TRAIL. Circulation. 2003 Oct 28; 108(17Suppl):IV-223.
  103. Erbel C, Meyer FB, Kopecky SL , Frye RL, Goronzy JJ, Weyand CM. Activated dendritic cells are key immunoregulators in unstable atherosclerotic plaque. Circulation. 2003 Oct 28; 108(17 Suppl):IV-98.
  104. Saint-Jacques H, Hellkamp AS, Kandzari DE, O'Connor CM, Daly R, Kopecky SL , Langer A, Vorchheimer D, O'Gara PT, Fuster V, Califf RM, Harrington RA. Predictors of Major Hemorrhage Following Initiation of Warfarin Therapy. (Abstract). JACC. 2004 Mar 3; 43(5) Supplement A: 444A.
  105. Lee V, Friedman PA, Gersh BJ, Hodge DO, Kopecky SL , Shen WK, Packer DL, Hammill SC, Jahangir A. Progression of paroxysmal lone atrial fibrillation to chronic atrial fibrillation:Long-term follow-up of the Mayo Clinic experience (Abstract 133). Heart Rhythm. 2004 May; 1(1 Suppl):S 43-4.
  106. Bybee KA, Powell B, Valeti U, Rosales AG, Kopecky S , Mullany C, Wright RS. Beneficial effect of pre-operative aspirin therapy on post-operative outcomes in patients undergoing coronary artery bypass grafting (Abstract 2210). Circulation. 2004 Oct;110(17):III-469.
  107. Jahangir A, Lee V, Friedman PA, Hodge DO, Kopecky SL , Packer DL, Hammill SC, Shen WK, Gersh BJ. Long-term risk of death, stroke, or TIA and heart failure in patients with long paroxysmal or persistent atrial fibrillation (Abstract 3098). Circulation. 2004 Oct;110(17):III-668.
  108. Niessner A, Zhang X, Deng J, Kopecky SL , Frye RL, Goronzy JJ, Weyand CM. CX3CR1, a cardiovascular disease risk gene, regulatestissue-damaging effector functions of T cells accumulated in the atherosclerotic plaque. Circulation. 2008; 118:S309.
  109. Montero-Gomez A, Terzic C, Mendoza C, Saavedra L, Kuniyoshi F, Thomas R, Kopecky S, Squires R, Vallejos J, Lopez-Jimenez F. Lack of cardiac rehabilitation programs in Latin America and the Caribbean. Circulation. 2008 Sep; 118(12):E426.
  110. Aijaz B, Allison TG, Thomas RJ, Lahr B, Lopez-Jimenez F, Kopecky SL . Comparison of metabolic syndrome and diabetes in predicting long-term all-cause. Circulation. 2008 Oct; 118(18 Suppl 2):S1088.
  111. Aijaz B, Haider Z, Kopecky SL , Squires RW, Thomas RJ, Allison TG. Low cardiorespiratory fitness fails to predict mortality in severe (Class II or greater) obesity. Circulation. 2008 Oct; 118(18 Suppl 2):S1143.
  112. Niessner A, Zhang XY, Deng JS, Kopecky SL , Frye RL, Goronzy JJ, Weyand CM. CX(3)CR1, a cardiovascular disease risk gene, regulates tissue-damaging effector functions of T cells accumulated in the atherosclerotic plaque. Circulation. 2008 Oct; 118(18 Suppl 2):S309.
  113. Al Badarin FJ, Kopecky SL , Allison TG. Exercise capacity predicts overall mortality beyond the Framingham risk score in patients without established coronary artery disease. J Am Coll Cardiol. 2009 Mar; 53(10 Suppl 1):A258.
  114. Abudiab M, Aijaz B, Konecny T, Kopecky SL , Squires RW, Thomas RJ, Allison TG. Results of Treadmill Stress Testing Need Not be Interpreted Differently For Predicting Mortality in Obese Patients. Circulation. 2010; 122:A16413.
  115. Dhoble A, Gupta B, Lopez-Jimenez F, Kopecky S . Value of exercise treadmill test in predicting 10-years cardiovascular risk in a referral population. J Am Coll Cardiol. 2012 Mar 27; 59(13):E1875.
  116. Wallace T, Heaney R, Kopecky S , Maki K, Hathcock J, MacKay D. Calcium supplements and the risk of myocardial infarction Experimental Biology. Apr 2012.
  117. Wallace TC, Heaney R, Kopecky SL , Maki KC, Hathcock J, MacKay D. Calcium supplements and the risk of myocardial infarction. FASEB J. 2012 Apr; 26.

Audio/Video/CD-ROM/etc.

  1. Kopecky SL . ACCEL - Lone Atrial Fibrillation January 1, 1988
  2. Kopecky SL . ACCEL - Long-term Follow-up of Pulmonary Stenosis June. 1988
  3. Kopecky SL . ACCEL-Lone Atrial Fibrillation. (interview) 1990 Jan.
  4. Kopecky SL . "Healthline" with Dr. L. E. Shelhamer. KSMQ-TV, Austin, MN, 1993 Jan 19
  5. Kopecky SL . "Healthline" Radio show with Dr. T. C. Shives. KROC Studios - Zumbro Valley Medical Society, Rochester, MN; 1993 Jun 26
  6. Kopecky SL . AudioDigest Internal Medicine - Managmeent Decisions in Atrial Fibrillation Vol 41 #18, 1994 Sep 19
  7. Kopecky SL . Management Decisions in Atrial Fibrillation. AudioDigest Internal Medicine, Vol 41 #18, 1994 Sep 19.
  8. Kopecky SLHealthline"Radio Show with Dr. T. C. Shives. KROC Studios - Zumbro Valley Medical Society, Rochester, MN; 1995 Mar 25
  9. Kopecky SL . "Healthline" Radio Show with Dr. T. C. Shives. KRSO Studios - Zumbro Valley Medical Society, Rochester, MN; 1996 May 11
  10. Kopecky SL . "Healthline" Radio Show with Dr. T. C. Shives KROC Studios - Zumbro Valley Medical Society, Rochester, MN. 1997 Apr 19
  11. Kopecky SL . Living with Cancer - A Message of Hope Mayo Clinic, Rochester, MN; September 25,1998
  12. Kopecky SL . "Healthline" Radio Show with Dr. T. C. Shives KROC Studios - Zumbro Valley Medical Society, Rochester, MN; 1998 Oct 3

Book Chapters

  1. Kopecky SL . Your Heart and Blood Circulation. Chapter 2 In: Mayo Clinic Complete Guide of Pregnancy and Baby's First Year 1st ed. New York: William Morrow and Company, Inc.; 1994. p. 20-2. (Book chapter)
  2. Kopecky SL . Supraventricular Arrhythmias. Part 4, Chapter 22 In: Mayo Clinic Practice of Cardiology St. Louis: Mosby; 1996. p. 748-79. (Book chapter)
  3. Wood DL, Hammill SC, Kopecky SL . Supraventricular Tachycardia. Pages 748-779 In: Giuliani ER, Gersh BJ, McGoon MD, Hayes DL, Schaff HV. Mayo Clinic Practice of Cardiology 3rd ed. Mosby: St. Louis; 1996. p. 748-79. (Book chapter)
  4. Wood DL, Hammill SC, Kopecky SL . Cardiac arrhythmias: B. Supraventricular arrhythmias. In: Giuliani ER, et al. Mayo Clinic Practice of Cardiology. Third ed. St. Louis: Mosby; 1996. p. 748-79. (Book chapter)
  5. Kopecky SL . Unstable Angina. Chapter 12 In: 1st. Mayo Clinic Cardiology Review Armonk: Futura Publishing Company, Inc.; 1997. p. 123-30.(Book chapter)
  6. Kopecky SL . Unstable angina. In: Murphy JG. Mayo Clinic Cardiology Review. Armonk: Futura Publishing Company, Inc.; 1997. p. 123-30. (Book chapter)
  7. Kopecky SL . Clinical trials and future directions of thrombolytic agents. In: Holmes Jr. DR, Serruys PW. Current Review of Interventional Cardiology. Third ed. Philadelphia: Churchill Livingstone; 1997. p. 169-74.(Book chapter)
  8. Murphy J, Wright R, Kopecky S , Reeder G. Management of Acute MI. Mayo Clinic Cardiology Review. Murphy J, Editor. 2nd Edition Lippincott-Raven Publishers, Philadelphia, 1999. (Book chapter)
  9. Kopecky SL . Unstable angina. In: Murphy JG. Mayo Clinic Cardiology Review. Second ed. Philadelphia: Lippincott Williams & Wilkins; 2000. p. 159-70. (Book chapter)
  10. Wright RS, Santrach PJ, Kopecky SL . Diagnosis of acute myocardial infarction. In: Murphy JG. Mayo Clinic Cardiology Review. Second ed. Philadelphia: Lippincott Williams & Wilkins; 2000. p. 171-4. (Book chapter)
  11. Murphy JG, Wright RS, Kopecky SL , Reeder GS. Management of acute myocardial infarction. In: Murphy JG. Mayo Clinic Cardiology Review. Second ed. Philadelphia: Lippincott Williams & Wilkins; 2000. p. 185-92. (Book chapter)
  12. Kopecky SL . Atrial fibrillation. In: Ferguson III JJ, et al. Antiplatelet Therapy in Clinical Practice. London: Martin Dunitz; 2000. p. 231-9.(Book chapter)
  13. Bybee KA, KopeckySL. Palpitations. In: Oliveira GHM, Nesbitt GC, Murphy JG. Mayo Clinic medical manual. Boca Raton: Mayo Clinic Scientific Press, Taylor & Francis Group; 2006. p. 233-8. (Book chapter)
  14. Bybee KA, Kopecky SL . Acute Myocardial Infarction. In: Rakel RE, Bope ET. Conn's Current Therapy 2006. 58th ed. Philadelphia, PA: Saunders Elsevier Inc.; 2006. p.434-443. (Book chapter)
  15. Kopecky SL . Restrictions on drivers and aircraft pilots with cardiac disease. In: Murphy JG, Lloyd MA. Mayo Clinic cardiology: concise textbook. 3rd ed. Rochester: Mayo Clinic Scientific Press : Informa Healthcare; 2007. p. 103-14. (Book chapter)
  16. Hilliard AA, Kopecky SL . Acute coronary syndromes. In: Murphy JG, Lloyd MA. Mayo Clinic cardiology: concise textbook. 3rd ed. Rochester: Mayo Clinic Scientific Press : Informa Healthcare; 2007. p. 781-93. (Book chapter)
  17. Wright RS, Kopecky SL , Murphy JG. Acute coronary syndromes. In: Murphy JG; et al editor. Mayo Clinic cardiology: concise textbook. 4th Edition. Rochester: Mayo Clinic Scientific Press; 2013. p. 615-26. (Book chapter)
  18. Kopecky SL . Restrictions on drivers and aircraft pilots with cardiac disease. In: Murphy JG; et al editor. Mayo Clinic cardiology: concise textbook. 4th Edition. Rochester: Mayo Clinic Scientific Press; 2013. p. 71-6. (Book chapter)

Editorials

  1. Kopecky SL . Stroke Prevention Dept Int Med Mayo Clinic Newsletter. 1993;15:1-3.
  2. Gussak I, Wright RS, Kopecky SL . Should we revise our diagnostic methods for Q-wavemyocardial infarction in the presence of right bundle branch block? Am Heart J. 2000 Jul;140(1):10-1. PMID:10874256.
  3. Kim TC, Rodeheffer RJ, Kopecky SL . Implementing clinical trial results into clinical practice for patients with heart failure. Am J Cardiol. 2003 Mar 1; 91(5):581-2. PMID:12615264.
  4. Kopecky SL , Nehra A. Cardiovascular risk and cholesterol management in men: implications of the new guidelines. Journal Of Mens Health. 2014 Jun; 11(2):51-2.

Letters

  1. Gersh BJ, McGoon MD, Kopecky SL , Whisnant JP, Holmes DR Jr. The risks of lone atrial fibrillation. N Engl J Med. 1988 Mar 10; 318:640. PMID:3344011.
  2. Brady PA, Al-Suwaidi J, Kopecky SL , Terzic A. Sulfonylureas and mortality in diabetic patients after myocardial infarction. Circulation. 1998 Feb 24; 97(7):709-10. PMID:9495313.
  3. Wright RS, Murphy JG, Bybee K, Kopecky SL . Determining optimal statin dosage - In reply. Mayo Clin Proc. 2003 Mar; 78(3):381.PMID:12630594.
  4. Gupta BP, Murad MH, Kopecky SL . Management of erectile dysfunction: Do not forget hypertension - Reply. Arch Intern Med. 2012; 172(7):598.

Miscellaneous

  1. Kopecky SL . Case Challenges: Statin-Associated Myalgia. Cardio Suurce.org. 2014.

Stephen L Kopecky

Professor

  • DEPARTMENTDivision of Cardiovascular Diseases
    Mayo Clinic
  • COUNTRY USA